Ireland· IE-PA-EU/1/14/973/001
Quinsair 240mg Nebuliser solution
A levofloxacin product containing levofloxacin, registered in Ireland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Levofloxacin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01MA12 (levofloxacin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Levofloxacin · ATC J01MA12
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levofloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), the median price runs from $0.68 in Italy to $3.14 in Switzerland — a ×4.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levofloxacin · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.14
- IT Italy$0.68
The record
At a glance
HPRA (Ireland)- Active substance
- Levofloxacin
- Manufacturer
- Chiesi Farmaceutici S.p.A.
- Country
- Ireland (IE)
- ATC code
- J01MA12
- ATC class
- Levofloxacin
- Defined daily dose
- 0.24 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/14/973/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
593 interactions on record for levofloxacin.
Graded by severity as the source publishes them — 125 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levofloxacin · interactions on record
593 records
- 125 severe
- 341 moderate
- 52 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PrednisoloneA07EA01severe
75 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levofloxacin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumQuinsair 240 mgChiesi Farmaceutici
- CanadaQUINSAIRHORIZON THERAPEUTICS IRELAND DAC
- SpainQUINSAIR 240 MG SOLUCION PARA INHALACION POR NEBULIZADORChiesi Farmaceutici S.P.A.
- FinlandQuinsairChiesi Farmaceutici S.p.A.
- IcelandQuinsairChiesi Farmaceutici S.p.A.*
- NetherlandsQuinsair 240 mg verneveloplossingChiesi Farmaceutici S.p.A.
- NorwayQuinsairChiesi Farmaceutici S.p.a.
- PolandQuinsairChiesi Farmaceutici S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Levofloxacin 1a Pharma, Levofloxacin Actavis
- Belgium · Levofloxacin Noridem, Levofloxacine Eg
- Bulgaria · Levofloxacin Kabi, Levor 5 Mg/Ml
- Cyprus · Amesol, Fairlim
- Czechia · Levofloxacin Aptapharma, Levofloxacin Kabi
- Germany · Levoflox, Levofloxacin 1 A Pharma
- Denmark · Levofloxacin Macure, Levofloxacin Noridem
- Estonia · Levnibiot, Levofloxacin Basi
- Spain · Bactyflox, Levofloxacin Sanovel
- Finland · Levofloxacin Fresenius Kabi, Levofloxacin Krka
- France · Levofloxacine Accord Healthcare, Levofloxacine Almus
- United Kingdom (Northern Ireland) · Evoxil, Eyflox
- Greece · Cinlevo, Evoxil
- Croatia · Flexid, Fovelid
- Hungary · Avatac, Leflokin
- Iceland · Oftaquix, Quinsair
- Italy · Agilev, Allgram
- Liechtenstein · Quinsair
- Lithuania · Levalox, Levofloxacin Actavis
- Luxembourg · Levofloxacine Eg, Levofloxacine Fresenius Kabi
- Latvia · Levalox, Levofloxacin Basi
- Malta · Evoxil, Floxaval
- Netherlands · Levofloxacin Hemihydrate Aurobindo, Levofloxacine Beximco
- Norway · Levofloxacin Macure, Levofloxacin Noridem Enterprises
- Poland · Levalox, Levocin
- Portugal · Lenovan, Levofloxacina
- Romania · Cenomar, Fleraday
- Sweden · Levofloxacin Actavis, Levofloxacin Krka
- Slovenia · Leviaben, Levofloksacin Aptapharma
- Slovakia · Levalox, Levofloxacin Aptapharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bff1d5a0-6f6a-468d-bd65-e054da722256 GET /v1/drugs/bff1d5a0-6f6a-468d-bd65-e054da722256?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nebuliser solution",
"routes": [
"Inhalation use"
],
"source": "hpra",
"atc_all": [
"J01MA",
"J01MA12"
],
"strength": null,
"pa_number": "EU/1/14/973/001",
"substances": [
"Levofloxacin"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/03/2015",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about levofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.